NASDAQ STOCKHOLM WELCOMES VIVOLINE MEDICAL TO FIRST NORTH
Stockholm, March 5, 2015 — Nasdaq (Nasdaq: NDAQ) announces that the trading in Vivoline Medical AB’s shares (short name: VIVO) commenced today on First North at Nasdaq Stockholm. Vivoline Medical, previously listed at Aktietorget, belongs to the Healthcare sector and is the eleventh company to be admitted to trading on Nasdaq’s Nordic markets* in 2015.
Vivoline Medical is pioneering the development of technologies to increase organ availability for transplantation. Vivoline is developing devices, disposables and solutions for heart transplantation and is currently offering a second generation system for lung transplantation LS2, to an international market, as well as preparing the launch of organ preservation solutions for lungs. The vision is to create a world leader whose products make it possible to use the majority of donor organs for transplantations. For more information, please visit www.vivoline.se.
“Vivoline is on the forefront of heart transplantation, lung transplantation, both stationary and portable devices, disposables and solutions. We hope that the investors at First North will appreciate the ground breaking science and technologies Vivoline is working with and compare our offer with other successful companies listed on First North.”
“We welcome Vivoline Medical to First North and to our Nasdaq-family of companies,” said Adam Kostyál, senior vice president and head of European listings at Nasdaq. “First North continues to attract innovative and entrepreneurial growth companies and Vivoline Medical is a great example of exactly that.”
Vivoline Medical has appointed Erik Penser Bankaktiebolag as Certified Adviser.
About First North
First North is regulated as a multilateral trading facility, operated by the different exchanges within Nasdaq Nordic (First North Denmark is regulated as an alternative marketplace). It does not have the legal status as an EU-regulated market. Companies at First North are subject to the rules of First North and not the legal requirements for admission to trading on a regulated market. The risk in such an investment may be higher than on the main market”
Nasdaq (Nasdaq: NDAQ) is a leading provider of trading, clearing, exchange technology, listing, information and public company services across six continents. Through its diverse portfolio of solutions, Nasdaq enables customers to plan, optimize and execute their business vision with confidence, using proven technologies that provide transparency and insight for navigating today's global capital markets. As the creator of the world's first electronic stock market, its technology powers more than 70 marketplaces in 50 countries, and 1 in 10 of the world's securities transactions. Nasdaq is home to more than 3,500 listed companies with a market value of over $9.1 trillion and more than 10,000 corporate clients. To learn more, visit http://nasdaq.com/ambition or http://business.nasdaq.com.
Nasdaq Copenhagen, Nasdaq Helsinki, Nasdaq Iceland, Nasdaq Riga, Nasdaq Stockholm, Nasdaq Tallinn, Nasdaq Vilnius, Nasdaq Clearing and Nasdaq Broker Services are respectively brand names for the regulated markets of Nasdaq OMX Copenhagen A/S, Nasdaq OMX Helsinki Ltd., Nasdaq OMX Iceland hf., Nasdaq OMX Riga, AS, Nasdaq OMX Stockholm AB, Nasdaq OMX Tallinn AS, AB Nasdaq OMX Vilnius, Nasdaq OMX Clearing AB, Nasdaq OMX Broker Services AB. Nasdaq Nordic represents the common offering by Nasdaq Copenhagen, Nasdaq Helsinki, Nasdaq Iceland and Nasdaq Stockholm. Nasdaq Baltic represents the common offering by Nasdaq Tallinn, Nasdaq Riga and Nasdaq Vilnius.
Cautionary Note Regarding Forward-Looking Statements
The matters described herein contain forward-looking statements that are made under the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. These statements include, but are not limited to, statements about Nasdaq and its products and offerings. We caution that these statements are not guarantees of future performance. Actual results may differ materially from those expressed or implied in the forward-looking statements. Forward-looking statements involve a number of risks, uncertainties or other factors beyond Nasdaq's control. These factors include, but are not limited to factors detailed in Nasdaq's annual report on Form 10-K, and periodic reports filed with the U.S. Securities and Exchange Commission. We undertake no obligation to release any revisions to any forward-looking statements.
|Media Relations Contact:|
|+46 8 405 6639|
Nasdaq Press Center
Read the latest press releases, request a press kit, and get in touch with our press team.